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Abstract Whipples disease is a rare systemic infectious
disease caused by the actinobacterium Tropheryma
whipplei. Spondylodiscitis is an extremely rare manifes-
tation of the infection and has previously been described
in only three case reports. We present a 55-year-old man
with persistent lumbago and signs of systemic illness, but
without any gastrointestinal symptoms or arthralgia.
The signal response in the lumbar spine in magnetic
resonance tomography, both native and after intrave-
nous gadolinium administration, was compatible with
spondylodiscitis at the L4/L5 level. Culture of a speci-
men obtained by radiographically guided disc puncture
and repeated blood cultures remained sterile. Trophe-
ryma whipplei was detected by PCR ampliﬁcation in
material obtained from the disc specimen, from a biopsy
of the terminal ileum and from the stool. The histology
of duodenum, terminal ileum, colon and disc material
was normal and, in particular, showed no PAS-positive
inclusions in macrophages. Long-term antibiotic treat-
ment with sulphamethoxazole and trimethoprim was
successful, with marked improvement of the low back
pain and normalisation of the systemic inﬂammatory
signs. The possibility of Whipples disease must be sus-
pected in the case of a culture-negative spondylodiscitis
even if there are no gastrointestinal symptoms and no
arthralgia present.
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Introduction
Whipples disease, ﬁrst described in 1907, is a systemic
infectious disease caused by Tropheryma whipplei. The
main clinical symptoms are diarrhoea, weight loss and
arthralgia, with cardiac or central nervous manifestations
being indicative of a poor prognosis [1, 2, 3]. The clinical
suspicion is usually conﬁrmedby the detection of diastase-
resistant, non-acid fast PAS (periodic acid–Schiﬀ stain)-
positive inclusions in macrophages of the small intestinal
mucosa, or the electronmicroscopic imaging of the typical
trilamellar cell membrane of the pathogen. Culture of the
organism has recently been described but is not available
for routine diagnosis [4, 5].Molecular genetic detection by
means of broad-spectrum PCR (polymerase chain reac-
tion) ampliﬁcation of the bacterial 16S ribosomal RNA
gene and subsequent identiﬁcation by sequencing of the
amplicon or by species-speciﬁc PCR is gaining increasing
diagnostic relevance [2, 6, 7, 8, 9].
We report a case of culture-negative spondylodiscitis
as the ﬁrst manifestation of Whipples disease in which
the pathogen was ﬁnally detected by broad-spectrum
PCR with DNA isolated from disc puncture biopsy
material.
Case report
A 55-year-old removal worker was hospitalised for
lumbago that had been refractory to physiotherapy and
analgesic medication for a year, with the appearance of
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lower lumbar pain at night over the past 4 months.
Systemic manifestations included loss of appetite, an
unintentional loss of 4 kg in weight over 4 months, and
occasional night sweats. Arthralgia and gastrointestinal
symptoms such as diarrhoea or increased stool fre-
quency were completely absent. The most prominent
clinical features were lower lumbar percussion pain and
the reduction of lumbar spinal mobility by two-thirds.
The neurological ﬁndings and peripheral joint status
were normal. The patient was afebrile.
The initial laboratory tests gave the following results:
ESR 52 mm/h, CRP 50 mg/l (reference range up to
10 mg/l), leucocytes 8.5·109/l with 48.5% stabnuclear;
haemoglobin 14.9 g/dl, platelets 506·109/l; four blood
cultures without microbial growth; immune ﬁxation of
serum and urine as well as PSA normal; HIV serology
negative.
Magnetic resonance tomography of the lumbar spine
revealed a sacralisation of the ﬁfth lumbar vertebra as
well as a considerable reduction in the height of the L4/
L5 intervertebral space, with erosive alterations of the
adjacent vertebral end plates (as previously documented
by plain radiographs). With T2 weighting the signal was
increased centrally in the L4/L5 disc and there was L4
and L5 vertebral body oedema, with marked enhance-
ment after gadolinium administration. Streaky
enhancement, more marked on the left, was also found
in the paravertebral space, but without evidence of a
paravertebral or epidural abscess (Figs 1a–1c and 2a and
b). A conventional chest X-ray and an abdominal CT
scan were normal.
We performed an invasive exploration by radio-
graphically guided disc puncture biopsy because of
persistent low back pain over 1 year with signs of sys-
temic disease and the development of lumbar pain also
at night and on percussion, together with elevated
inﬂammatory parameters and a marked left shift in the diﬀerential blood count, as well as a magnetic resonance
tomography scan suggesting L4/L5 spondylodiscitis
with an absence of microbial growth in four blood cul-
tures.
Culture of the disc puncture biopsy material,
including cultivation for Mycobacterium tuberculosis,
revealed no microbial growth. Oesophageogastroduo-
denoscopy was normal, as was coloileoscopy, apart from
a small ulcer on the ileocaecal valve. Histologically, the
disc puncture biopsy material showed partially necrotic,
partially degeneratively altered ﬁbrous cartilage in pla-
Fig. 1 Magnetic resonance tomography of the lumbar spine, both
native and after intravenous gadolinium. a MRI of lumbar spine,
sagittal, T1 weighting; b MRI of lumbar spine, sagittal, T2
weighting; c MRI of lumbar spine, sagittal, fat-suppressed and
after i.v. gadolinium. Lumbar L4/L5 disc reduced in height, with
central T2 hyperintense signal. Erosive alterations of L4 bottom
plate and L5 top plate, as well as bone marrow oedema of both
vertebral bodies (more marked on the left) with enhancement after
intravenous gadolinium. No epidural or paravertebral abscess
Fig. 2 a MRI of L4 lumbar vertebra, horizontal, fat-suppressed
and after i.v. gadolinium; bMRI of lumbosacral transition, frontal,
fat-suppressed and after i.v. gadolinium. Left-accentuated enhance-
ment of L4 and L5 vertebral bodies with streaky paravertebral
enhancement, more marked on the left. No abscess formation.
Erosive alterations of the L4/L5 end plates with enhancement,
central enhancement in the height-reduced disc. Degenerative
spinal canal stenosis
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ces. The histology of the biopsy material from duode-
num, terminal ileum and colon was normal, apart from
regenerative epithelial fragments and granulation tissue
in the area of the small ileocaecal valve ulcer. In par-
ticular, no PAS-positive inclusions in macrophages were
detected.
In contrast, broad-spectrum PCR [9] revealed T.
whipplei DNA in material from the L4/L5 disc puncture
biopsy. This result was conﬁrmed by two diﬀerent spe-
cies-speciﬁc real-time PCR assays targeting the 16S
rDNA and an open reading frame of unknown function,
respectively [10]. Biopsies from terminal ileum and
colon, as well as a stool sample, were also positive
using the speciﬁc assay targeting the 16S rDNA, but
no T. whipplei DNA was found in an EDTA blood
sample.
Antibiotic therapy with sulphamethoxazole and tri-
methoprim (800 mg plus 160 mg twice daily; additional
folic acid substitution) led to normalisation of the
inﬂammatory parameters within 1 month, and the pa-
tient was asymptomatic and fully able to work 5 months
after starting therapy.
Discussion
To our knowledge, only three cases of Whipples disease
with spondylodiscitis as the main manifestation have
been reported [9, 11, 12]. There seems to be an accu-
mulation of cases of Whipples disease with unusual
presentation in the Zurich area and eastern Switzerland,
as 3 of the 4 spondylitis cases as well as at least 7 other
cases have been observed in this geographical area
within a short time (four cases of endocarditis, one each
with involvement of the CNS, the bone marrow and the
joints, respectively) [11, 13, 14, 15]. In one of these 7
patients, PAS-positive bacteria were detected in bone
marrow biopsy material [15]. We assume that the high
incidence of Whipples disease found in the Zurich area
is not related to a peculiar epidemiologic situation but
rather to the increased use of molecular methods for the
analysis of unclear infections, especially the broad-
spectrum PCR on usually sterile specimens.
A notable feature of our case is the absence of gas-
trointestinal symptoms and arthralgia. In recent years
there has been an increasing number of reports of vari-
ous organ manifestations of Whipples disease without
clinical or histological evidence for an involvement of
the gastrointestinal tract [9, 11, 13].
The indication for invasive exploration was based on
several red ﬂags for a secondary form of low back pain
that had been refractory to treatment for 1 year. Apart
from lower lumbar pain at night and on percussion,
signs of systemic disease developed, with loss of appetite,
weight loss and night sweats combined with elevated
inﬂammatory parameters and a left shift in the diﬀer-
ential blood count. The signal alteration in a magnetic
resonance tomography scan of the lumbar spine was
compatible with spondylodiscitis. Repeated blood cul-
tures failed to show microbial growth and there was no
evidence of any underlying neoplastic disease.
After we failed to detect any pathogen in the L4/L5
disc puncture biopsy material by histological examina-
tion and conventional culture, the specimen was exam-
ined by broad-spectrum PCR. Sequencing of the
amplicon revealed T. whipplei in the material from the
disc puncture biopsy. We did not attempt to culture
T. whipplei using cell cultures because at the time the
specimens were taken, Whipples disease was not sus-
pected clinically. This illustrates the usefulness of broad-
spectrum PCR, which detects any bacterium if present in
suﬃcient numbers. The presence of T. whipplei was
subsequently conﬁrmed with two independent species-
speciﬁc PCR assays with DNA from the disc puncture
biopsy, as well as by a positive PCR from duodenum
and colon biopsies, respectively. Despite positive PCR
results, the histological ﬁndings in material from the
duodenum, terminal ileum, colon and disc puncture
biopsy were normal, and in particular there were no
PAS-positive inclusions in macrophages.
T. whipplei seems to be a rather common environ-
mental organism and is detectable in the gastrointestinal
tract of a signiﬁcant proportion of asymptomatic carri-
ers. In a prospective study with elective gastroscopy in
105 patients without signs of Whipples disease, positive
results were obtained by PCR ampliﬁcation in 11.4% of
gastric juice aspirates and 4.8% of duodenal biopsies
[16]. These results were conﬁrmed in a follow-up study,
with 6 of 14 initially positive subjects being also positive
in saliva [17]. Similarly, T. whipplei DNA was detected
by PCR in the saliva of 35% of 40 healthy persons [18],
with results remaining positive in a repeat test. In con-
trast, T. whipplei DNA has not so far been reported
from usually sterile locations (joints, cerebrospinal ﬂuid)
from persons without Whipples disease. Gene sequences
speciﬁc for T. whipplei were also found in 25 of 38
eﬄuent water samples from ﬁve diﬀerent sewage plants
in southern Germany [19]. Whether these ﬁndings in-
deed indicate environmental occurrence of the organism
is debatable, as it may as well simply reﬂect fecal
excretion. T. whipplei may be a commensal bacterium
that leads to systemic infection only under special, as yet
undeﬁned circumstances, such as macrophage dysfunc-
tion. Despite this possible widespread environmental
occurrence, a positive ﬁnding of speciﬁc DNA by PCR
in the context of an infection of a normally sterile body
site can be considered diagnostic.
The recent sequencing of the complete T. whipplei
genome provides new insights into the biology of this
pathogen, with the possible perspective of new diag-
nostic strategies [20].
In summary, the possibility of Whipples disease must
be suspected in the case of a culture negative spondy-
lodiscitis, even if there are no gastrointestinal symptoms
and no arthralgia present. Compared to histological
detection of non-acid-fast PAS-positive macrophage
inclusions, PCR ampliﬁcation of the speciﬁc 16S rRNA
gene sequences of T. whipplei is more sensitive and
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allows early diagnosis and the introduction of long-term
antibiotic therapy.
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